ALLIANCEBERNSTEIN L.P.

Position in CCCC — C4 Therapeutics, Inc.

CIK 1109448 NASHVILLE, TN

Position in CCCC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$302,522

+$226,042 QoQ

Shares Held

64,780

+35.5% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#80

of 147 holders

Holding Since

Jun 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ALLIANCEBERNSTEIN L.P. holds $5,177,847,011 across 257 Biotechnology names. CCCC ranks #198 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,019,315	$1,499,784,339
2	ARGX	Argenx SE	395,661	$367,082,405
3	GMAB	Genmab A/S	8,644,877	$237,474,771
4	REGN	Regeneron Pharmaceuticals, Inc.	292,338	$182,284,436
5	TECH	BIO-TECHNE Corp	2,002,026	$141,443,136
6	HALO	Halozyme Therapeutics, Inc.	1,696,538	$132,788,029
7	KYMR	Kymera Therapeutics, Inc.	981,521	$112,551,013
8	BBIO	BridgeBio Pharma, Inc.	1,453,504	$108,256,977

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$302,522	64,780	+35.5%	Shares	Defined	2026-08-14
2025-03-31	$76,480	47,800	0.0%	Shares	Defined	2025-05-15
2024-12-31	$172,080	47,800	0.0%	Shares	Defined	2025-02-12
2024-09-30	$272,460	47,800	+4.4%	Shares	Defined	2024-11-14
2024-06-30	$211,503	45,780	-12.0%	Shares	Defined	2024-08-14
2023-03-31	$163,280	52,000	0.0%	Shares	Defined	2023-05-15
2022-12-31	$306,800	52,000	+9.0%	Shares	Defined	2023-02-15
2022-09-30	$418,329	47,700	-6.1%	Shares	Defined	2022-11-15
2022-06-30	$383,032	50,800	-64.9%	Shares	Defined	2022-08-15
2022-03-31	$3,510,931	144,721	+41.1%	Shares	Defined	2022-05-13
2021-12-31	$3,302,657	102,567	+26.3%	Shares	Defined	2022-02-14
2021-09-30	$3,627,881	81,197	+32.5%	Shares	Defined	2021-11-10
2021-06-30	$2,318,910	61,282	—	Shares	Defined	2021-07-30
No filing history on record for this holder in this stock.